
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc.(IDYA)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
idya · 股价预测 · 25 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 25 位华尔街分析师
Buy
25 位分析师
共识
评级分布
12 个月目标价
High
$65.00
Consensus
$58.67
+99.7% upside
Low
$53.00
Median: $58 · Last Close: $29.38
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$58.67
99.7% upside
High Target
$65
121.2%
Low Target
$53
80.4%
Current Price
$29.38
as of today
Based on analyst price targets, the IDYA stock price prediction for the next 12 months ranges from $53 to $65. The consensus IDYA price forecast of $58.67 implies 99.7% upside from the current price of $29.38.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $29.21 | ↓ 0.58% |
1-day model range: $29.09–$29.33. Peak: $29.33 (-0.58%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $32 | +9.9% |
| 2028 | $34 | +16.4% |
| 2029 | $35 | +20.6% |
| 2030 | $36 | +23.2% |
| 2031 | — | +24.8% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IDYA · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-02 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-07 | Mizuho | Maintains | Outperform→Outperform |
| 2026-04-14 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-04-14 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2026-04-14 | Guggenheim | Maintains | Buy→Buy |
| 2026-04-14 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-14 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-03-31 | Wedbush | Maintains | Outperform→Outperform |
| 2026-02-19 | Citigroup | Maintains | Buy→Buy |
| 2026-02-18 | RBC Capital | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on IDEAYA Biosciences, Inc. (IDYA) stock. Of the recent 102 rating actions, 3 were upgrades and 2 were downgrades. 25 analysts currently cover IDYA.
分析师推荐趋势
IDYA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$35M
↓ 86.7% YoY
Revenue Next Year
$117M
↑ 236.1% YoY
EPS This Year
$-4.39
EPS Next Year
$-3.79
↓ 13.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast IDYA EPS of $-4.39 for the current fiscal year, based on estimates from 13 analysts. The IDYA revenue forecast is $35M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
IDYA 股价预测由两类独立数据源支撑:来自 25 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。IDYA 的共识目标价为 $58.67(+99.7% 上行空间),分析师共识为 Buy。
IDYA 的短期预测(明日)为 $29.21(-0.58%)。 IDYA 对 2027 年的股价预测均值为 $32。 IDYA 对 2030 年的预测区间为 $35–$38。
IDEAYA Biosciences, Inc. 在 NASDAQ 上市,代码 IDYA。IDYA 在 2027 年的整体展望偏积极,在覆盖分析师中约 92% 对应 Buy 共识。
常见问题
IDYA 预测 · 8 个问题根据 25 位华尔街分析师,IDYA 的 12 个月平均目标价为 $58.67,最高 $65.00、最低 $53.00。若有图表,中位目标价可在上方查看。相对当前价 $29.38,隐含约 +99.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.